{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T10:06:10Z","timestamp":1790157970520,"version":"4.1.0"},"reference-count":27,"publisher":"American Society of Hematology","issue":"5","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2008,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Posttranslationally modified histones and DNA hypermethylation frequently interplay to deregulate gene expression in cancer. We report that acute myeloid leukemia (AML) with an aberrant histone methyltransferase, the mixed lineage leukemia partial tandem duplication (MLL-PTD), exhibits increased global DNA methylation versus AML with MLL-wildtype (MLL-WT; P = .02). Among the differentially methylated genes, the SLC5A8 tumor suppressor gene (TSG) was more frequently hypermethylated (P = .003). In MLL-PTD+ cell lines having SLC5A8 promoter hypermethylation, incubation with decitabine activated SLC5A8 expression. Ectopic SLC5A8 expression enhanced histones H3 and H4 acetylation in response to the histone deacetylase inhibitor, valproate, consistent with the encoded protein\u2014SMCT1\u2014short-chain fatty acid transport function. In addition, enhanced cell death was observed in SMCT1-expressing MLL-PTD+ AML cells treated with valproate. Within the majority of MLL-PTD AML is a mechanism in which DNA hypermethylation silences a TSG that, together with MLL-PTD, can contribute further to aberrant chromatin remodeling and altered gene expression.<\/jats:p>","DOI":"10.1182\/blood-2008-01-128595","type":"journal-article","created":{"date-parts":[[2008,6,19]],"date-time":"2008-06-19T21:41:31Z","timestamp":1213911691000},"page":"2013-2016","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":63,"title":["DNA hypermethylation and epigenetic silencing of the tumor suppressor gene, SLC5A8, in acute myeloid leukemia with the MLL partial tandem duplication"],"prefix":"10.1182","volume":"112","author":[{"given":"Susan P.","family":"Whitman","sequence":"first","affiliation":[{"name":"Comprehensive Cancer Center,"},{"name":"Division of Hematology-Oncology, Department of Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f6rn","family":"Hackanson","sequence":"additional","affiliation":[{"name":"Department of Molecular Virology, Immunology, and Medical Genetics, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandya","family":"Liyanarachchi","sequence":"additional","affiliation":[{"name":"Department of Molecular Virology, Immunology, and Medical Genetics, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shujun","family":"Liu","sequence":"additional","affiliation":[{"name":"Comprehensive Cancer Center,"},{"name":"Division of Hematology-Oncology, Department of Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura J.","family":"Rush","sequence":"additional","affiliation":[{"name":"Comprehensive Cancer Center,"},{"name":"Department of Veterinary Biosciences, The Ohio State University, Columbus; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kati","family":"Maharry","sequence":"additional","affiliation":[{"name":"Comprehensive Cancer Center,"},{"name":"Cancer and Leukemia Group B Statistical Center, Duke University, Durham, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean","family":"Margeson","sequence":"additional","affiliation":[{"name":"Comprehensive Cancer Center,"},{"name":"Cancer and Leukemia Group B Statistical Center, Duke University, Durham, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramana","family":"Davuluri","sequence":"additional","affiliation":[{"name":"Department of Molecular Virology, Immunology, and Medical Genetics, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wen","sequence":"additional","affiliation":[{"name":"Comprehensive Cancer Center,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana","family":"Witte","sequence":"additional","affiliation":[{"name":"Comprehensive Cancer Center,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Molecular Virology, Immunology, and Medical Genetics, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunhui","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Molecular Virology, Immunology, and Medical Genetics, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara D.","family":"Bloomfield","sequence":"additional","affiliation":[{"name":"Comprehensive Cancer Center,"},{"name":"Division of Hematology-Oncology, Department of Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Marcucci","sequence":"additional","affiliation":[{"name":"Comprehensive Cancer Center,"},{"name":"Division of Hematology-Oncology, Department of Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Plass","sequence":"additional","affiliation":[{"name":"Department of Molecular Virology, Immunology, and Medical Genetics, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Caligiuri","sequence":"additional","affiliation":[{"name":"Comprehensive Cancer Center,"},{"name":"Division of Hematology-Oncology, Department of Medicine,"},{"name":"Department of Molecular Virology, Immunology, and Medical Genetics, and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2019111722454638300_B1","first-page":"370","article-title":"Molecular rearrangement of the ALL-1 gene in acute myeloid leukemia without cytogenetic evidence of 11q23 chromosomal translocations.","volume":"54","author":"Caligiuri","year":"1994","journal-title":"Cancer Res"},{"key":"2019111722454638300_B2","first-page":"55","article-title":"Re-arrangement of ALL1 (MLL) in acute myeloid leukemia with normal cytogenetics.","volume":"58","author":"Caligiuri","year":"1998","journal-title":"Cancer Res"},{"key":"2019111722454638300_B3","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/S1097-2765(02)00740-2","article-title":"ALL-1 is a histone methyltransferase that assembles a supercomplex of proteins involved in transcriptional regulation.","volume":"10","author":"Nakamura","year":"2002","journal-title":"Mol Cell"},{"key":"2019111722454638300_B4","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/S1097-2765(02)00741-4","article-title":"MLL targets SET domain methyltransferase activity to Hox gene promoters.","volume":"10","author":"Milne","year":"2002","journal-title":"Mol Cell"},{"key":"2019111722454638300_B5","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1172\/JCI25546","article-title":"Mll partial tandem duplication induces aberrant Hox expression in vivo via specific epigenetic alterations.","volume":"116","author":"Dorrance","year":"2006","journal-title":"J Clin Invest"},{"key":"2019111722454638300_B6","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1182\/blood-2005-01-0204","article-title":"The MLL partial tandem duplication: evidence for recessive gain-of-function in acute myeloid leukemia identifies a novel patient subgroup for molecular-targeted therapy.","volume":"106","author":"Whitman","year":"2005","journal-title":"Blood"},{"key":"2019111722454638300_B7","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/sj.leu.2401773","article-title":"Screening for MLL tandem duplication in 387 unselected patients with AML identify a prognostically unfavorable subset of AML.","volume":"14","author":"Schnittger","year":"2000","journal-title":"Leukemia"},{"key":"2019111722454638300_B8","doi-asserted-by":"crossref","first-page":"3254","DOI":"10.1200\/JCO.2002.09.088","article-title":"Prognostic significance of partial tandem duplications of the MLL gene in adult patients 16 to 60 years old with acute myeloid leukemia and normal cytogenetics: a study of the Acute Myeloid Leukemia Study Group Ulm.","volume":"20","author":"D\u00f6hner","year":"2002","journal-title":"J Clin Oncol"},{"key":"2019111722454638300_B9","first-page":"500a","article-title":"Prognostic significance of partial tandem duplications of the MLL gene in acute myeloid leukemia with normal cytogenetics: A study within a multicenter treatment trial [abstract].","volume":"94","author":"D\u00f6hner","year":"1999","journal-title":"Blood"},{"key":"2019111722454638300_B10","doi-asserted-by":"crossref","first-page":"5164","DOI":"10.1182\/blood-2007-01-069831","article-title":"Long-term disease-free survivors with cytogenetically normal acute myeloid leukemia and MLL partial tandem duplication: a Cancer and Leukemia Group B study.","volume":"109","author":"Whitman","year":"2007","journal-title":"Blood"},{"key":"2019111722454638300_B11","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.leukres.2004.11.014","article-title":"Methylation of p15(INK4b) and E-cadherin genes is independently correlated with poor prognosis in acute myeloid leukemia.","volume":"29","author":"Shimamoto","year":"2005","journal-title":"Leuk Res"},{"key":"2019111722454638300_B12","first-page":"855","article-title":"Targeting epigenetic changes in acute myeloid leukemia.","volume":"3","author":"Blum","year":"2005","journal-title":"Clin Adv Hematol Oncol"},{"key":"2019111722454638300_B13","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1158\/0008-5472.CAN-04-4532","article-title":"Interplay of RUNX1\/MTG8 and DNA methyltransferase 1 in acute myeloid leukemia.","volume":"65","author":"Liu","year":"2005","journal-title":"Cancer Res"},{"key":"2019111722454638300_B14","doi-asserted-by":"crossref","first-page":"3617","DOI":"10.1158\/0008-5472.CAN-05-0048","article-title":"Shared epigenetic mechanisms in human and mouse gliomas inactivate expression of the growth suppressor SLC5A8.","volume":"65","author":"Hong","year":"2005","journal-title":"Cancer Res"},{"key":"2019111722454638300_B15","doi-asserted-by":"crossref","first-page":"8412","DOI":"10.1073\/pnas.1430846100","article-title":"SLC5A8, a sodium transporter, is a tumor suppressor gene silenced by methylation in human colon aberrant crypt foci and cancers.","volume":"100","author":"Li","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2019111722454638300_B16","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1210\/jc.2004-1394","article-title":"Silencing of the tumor suppressor gene SLC5A8 is associated with BRAF mutations in classical papillary thyroid carcinomas.","volume":"90","author":"Porra","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"2019111722454638300_B17","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1159\/000079145","article-title":"Aberrant methylation and histone deacetylation associated with silencing of SLC5A8 in gastric cancer.","volume":"25","author":"Ueno","year":"2004","journal-title":"Tumour Biology"},{"key":"2019111722454638300_B18","doi-asserted-by":"crossref","first-page":"7270","DOI":"10.1073\/pnas.0602365103","article-title":"Na(+)\/monocarboxylate transport (SMCT) protein expression correlates with survival in colon cancer: molecular characterization of SMCT.","volume":"103","author":"Paroder","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2019111722454638300_B19","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1042\/BST0330237","article-title":"Biological functions of SLC5A8, a candidate tumour suppressor.","volume":"33","author":"Ganapathy","year":"2005","journal-title":"Biochem Soc Trans"},{"key":"2019111722454638300_B20","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1016\/j.lfs.2005.10.028","article-title":"SLC5A8 (SMCT1)-mediated transport of butyrate forms the basis for the tumor suppressive function of the transporter.","volume":"78","author":"Gupta","year":"2006","journal-title":"Life Sciences"},{"key":"2019111722454638300_B21","doi-asserted-by":"crossref","first-page":"4325","DOI":"10.1182\/blood-2002-03-0772","article-title":"Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461).","volume":"100","author":"Byrd","year":"2002","journal-title":"Blood"},{"key":"2019111722454638300_B22","doi-asserted-by":"crossref","first-page":"3159","DOI":"10.1038\/sj.onc.1202651","article-title":"Restriction landmark genome scanning for aberrant methylation in primary refractory and relapsed acute myeloid leukemia; involvement of the WIT-1 gene.","volume":"18","author":"Plass","year":"1999","journal-title":"Oncogene"},{"key":"2019111722454638300_B23","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.leukres.2003.09.013","article-title":"New cytokine-dependent acute myeloid leukemia cell line MUTZ-11 with disomic chromosome rearrangement t(16;17).","volume":"28","author":"Hu","year":"2004","journal-title":"Leuk Res"},{"key":"2019111722454638300_B24","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1038\/sj.leu.2402911","article-title":"MLL partial tandem duplications in acute leukemia cell lines.","volume":"17","author":"Quentmeier","year":"2003","journal-title":"Leukemia"},{"key":"2019111722454638300_B25","doi-asserted-by":"crossref","first-page":"6236","DOI":"10.1073\/pnas.91.13.6236","article-title":"ALL-1 partial duplication in acute leukemia.","volume":"91","author":"Schichman","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2019111722454638300_B26","article-title":"Finding Groups In Data, An Introduction to Cluster Analysis.","author":"Kaufmann","year":"1990"},{"key":"2019111722454638300_B27","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1186\/1471-2164-8-446","article-title":"Restriction landmark genomic scanning (RLGS) spot identification by second generation virtual RLGS in multiple genomes with multiple enzyme combinations.","volume":"8","author":"Smiraglia","year":"2007","journal-title":"BMC Genomics"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/112\/5\/2013\/1486311\/zh801708002013.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/112\/5\/2013\/1486311\/zh801708002013.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,17]],"date-time":"2019-11-17T22:46:22Z","timestamp":1574030782000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/112\/5\/2013\/25450\/DNA-hypermethylation-and-epigenetic-silencing-of"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9,1]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,9,1]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2008-01-128595","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1116496.572522","asserted-by":"object"}]},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,9,1]]}}}